Deerfield to Take Singular Genomics Private in $50.2M Deal

Dow Jones

2024/12/23

By Dean Seal

Singular Genomics Systems has agreed to be acquired and taken private by an affiliate of Deerfield Management for $20 a share.

The deal is valued at $50.2 million based on the company's 2.51 million outstanding shares, according to FactSet. It is expected to close in the first half of next year.

Deerfield submitted a nonbinding proposal to acquire the company back in September, saying at the time that it sought an acquisition at $10 a share. The stock closed at a record low of $5.65 on the same day Deerfield's proposal was made public.

The private-equity firm upped its offer to $24 a share in early November, following negotiations between Deerfield and a special committee of the Singular Genomics board.

The special committee has signed off on the deal announced on Monday, though the transaction is still subject to stockholder approval. If the transaction is completed, Singular Genomics will become a private company.

Write to Dean Seal at dean.seal@wsj.com

(END) Dow Jones Newswires

December 23, 2024 09:31 ET (14:31 GMT)

Copyright (c) 2024 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2493276513"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2493276513\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2493276513?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-12-23 22:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2493276513","market":"hk","top_or_hot":-1,"title":"Deerfield to Take Singular Genomics Private in $50.2M Deal","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Singular Genomics Systems has agreed to be acquired and taken private by an affiliate of Deerfield Management for $20 a share. \n</p>\n<p>\n  The deal is valued at $50.2 million based on the company's 2.51 million outstanding shares, according to FactSet. It is expected to close in the first half of next year. \n</p>\n<p>\n  Deerfield submitted a nonbinding proposal to acquire the company back in September, saying at the time that it sought an acquisition at $10 a share. The stock closed at a record low of $5.65 on the same day Deerfield's proposal was made public. \n</p>\n<p>\n  The private-equity firm upped its offer to $24 a share in early November, following negotiations between Deerfield and a special committee of the Singular Genomics board. \n</p>\n<p>\n  The special committee has signed off on the deal announced on Monday, though the transaction is still subject to stockholder approval. If the transaction is completed, Singular Genomics will become a private company. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 23, 2024 09:31 ET (14:31 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Deerfield to Take Singular Genomics Private in $50.2M Deal</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDeerfield to Take Singular Genomics Private in $50.2M Deal\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2024-12-23 22:31</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre>\n \n</pre>\n<p>\n  By Dean Seal \n</p>\n<pre>\n \n</pre>\n<p>\n  Singular Genomics Systems has agreed to be acquired and taken private by an affiliate of Deerfield Management for $20 a share. \n</p>\n<p>\n  The deal is valued at $50.2 million based on the company's 2.51 million outstanding shares, according to FactSet. It is expected to close in the first half of next year. \n</p>\n<p>\n  Deerfield submitted a nonbinding proposal to acquire the company back in September, saying at the time that it sought an acquisition at $10 a share. The stock closed at a record low of $5.65 on the same day Deerfield's proposal was made public. \n</p>\n<p>\n  The private-equity firm upped its offer to $24 a share in early November, following negotiations between Deerfield and a special committee of the Singular Genomics board. \n</p>\n<p>\n  The special committee has signed off on the deal announced on Monday, though the transaction is still subject to stockholder approval. If the transaction is completed, Singular Genomics will become a private company. \n</p>\n<pre>\n \n</pre>\n<p>\n  Write to Dean Seal at dean.seal@wsj.com \n</p>\n<pre>\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  December 23, 2024 09:31 ET (14:31 GMT)\n</p>\n<p>\n  Copyright (c) 2024 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"OMIC","symbol_name":"Singular Genomics Systems Inc.","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2493276513","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2493276513","pubTimestamp":1734964260,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Singular Genomics Systems has agreed to be acquired and taken private by an affiliate of Deerfield Management for $20 a share.The deal is valued at $50.2 million based on the company's 2.51 million outstanding shares, according to FactSet. It is expected to close in the first half of next year.Deerfield submitted a nonbinding proposal to acquire the company back in September, saying at the time that it sought an acquisition at $10 a share. The stock closed at a record low of $5.65 on the same day Deerfield's proposal was made public.The private-equity firm upped its offer to $24 a share in early November, following negotiations between Deerfield and a special committee of the Singular Genomics board.The special committee has signed off on the deal announced on Monday, though the transaction is still subject to stockholder approval. If the transaction is completed, Singular Genomics will become a private company.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"OMIC":"Singular Genomics Systems Inc.","BK4551":"寇图资本持仓","BK4539":"次新股","BK4121":"生命科学工具和服务"},"translate_title":"Deerfield将以5020万美元的价格将Singular Genomics私有化","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"OMIC":0.9},"content_text":"By Dean Seal \n\n\n \n\n\n  Singular Genomics Systems has agreed to be acquired and taken private by an affiliate of Deerfield Management for $20 a share. \n\n\n  The deal is valued at $50.2 million based on the company's 2.51 million outstanding shares, according to FactSet. It is expected to close in the first half of next year. \n\n\n  Deerfield submitted a nonbinding proposal to acquire the company back in September, saying at the time that it sought an acquisition at $10 a share. The stock closed at a record low of $5.65 on the same day Deerfield's proposal was made public. \n\n\n  The private-equity firm upped its offer to $24 a share in early November, following negotiations between Deerfield and a special committee of the Singular Genomics board. \n\n\n  The special committee has signed off on the deal announced on Monday, though the transaction is still subject to stockholder approval. If the transaction is completed, Singular Genomics will become a private company. \n\n\n \n\n\n  Write to Dean Seal at dean.seal@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 23, 2024 09:31 ET (14:31 GMT)\n\n\n  Copyright (c) 2024 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":true,"code":"91000000","status":"200"}}}